We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABTS icon
13126
PUT
Abits Group
ABTS
$4.09M
$19K ﹤0.01%
773
-1,394
-64% -$41.1K
ATHE
13127
Alterity Therapeutics
ATHE
$80.7M
$19K ﹤0.01%
+2,358
New +$19.6K
BLRX
13128
CALL
BioLineRX
BLRX
$11.8M
$19K ﹤0.01%
275
-253
-48% -$17.6K
BYFC icon
13129
Broadway Financial
BYFC
$103M
$19K ﹤0.01%
+1,477
New +$21.5K
CDTX
13130
CALL
DELISTED
Cidara Therapeutics
CDTX
$19K ﹤0.01%
1,140
+460
+68% +$7.8K
CELG.RT
13131
Bristol-Myers Squibb Rights
CELG.RT
$224M
$19K ﹤0.01%
125,096
-86,129
-41% -$14K
DBVT
13132
CALL
DBV Technologies
DBVT
$847M
$19K ﹤0.01%
1,210
-210
-15% -$3.17K
GNLN icon
13133
CALL
Greenlane Holdings
GNLN
$1.23M
0
GOVX icon
13134
GeoVax Labs
GOVX
$4.01M
$19K ﹤0.01%
+44
New +$35K
LGHL
13135
PUT
Lion Group Holding
LGHL
$831K
0
OGI
13136
Organigram Holdings
OGI
$139M
$19K ﹤0.01%
2,860
-530,946
-99% -$3.28M
SATLW icon
13137
Satellogic Inc Warrant
SATLW
$79M
$19K ﹤0.01%
+25,190
New +$15K
SNTG icon
13138
Sentage Holdings
SNTG
$5.41M
$19K ﹤0.01%
3,521
-5,576
-61% -$25.4K
UAMY icon
13139
PUT
United States Antimony
UAMY
$1.02B
$19K ﹤0.01%
29,000
-20,900
-42% -$10.2K
VIVO
13140
VivoPower PLC
VIVO
$124M
$19K ﹤0.01%
1,088
-2,683
-71% -$61.8K
PIXY
13141
CALL
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$19K ﹤0.01%
1
CEMI
13142
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$19K ﹤0.01%
23,000
-2,900
-11% -$2.71K
CELP
13143
DELISTED
Cypress Environmental Partners, L.P.
CELP
$19K ﹤0.01%
+11,374
New +$14.5K
AQMS icon
13144
PUT
Aqua Metals
AQMS
$10.2M
$18K ﹤0.01%
59
-137
-70% -$31.1K
AXDX
13145
CALL
DELISTED
Accelerate Diagnostics
AXDX
$18K ﹤0.01%
1,230
+30
+3% +$854
CLWT icon
13146
Euro Tech Holdings
CLWT
$11.8M
$18K ﹤0.01%
+11,618
New +$18.3K
CNSP icon
13147
CNS Pharmaceuticals
CNSP
$7.86M
0
EFOI icon
13148
Energy Focus
EFOI
$20.3M
$18K ﹤0.01%
+1,893
New +$23.6K
EZGO
13149
EZGO Technologies
EZGO
$2.44M
0
ITRM
13150
DELISTED
Iterum Therapeutics
ITRM
$18K ﹤0.01%
3,368
+1,875
+126% +$10.8K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.